Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages.
about
Increased expression of ICAM-1, VCAM-1, MCP-1, and MIP-1 alpha by spinal perivascular macrophages during experimental allergic encephalomyelitis in rats.The use of flow cytometry to assess a novel drug efficacy in multiple sclerosisA cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitisCellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virus.Differential roles of microglia and monocytes in the inflamed central nervous systemMonocyte behaviour and tissue transglutaminase expression during experimental autoimmune encephalomyelitis in transgenic CX3CR1gfp/gfp miceRoles of PI3K and JAK pathways in viability of retinal ganglion cells after acute elevation of intraocular pressure in rats with different autoimmune backgrounds.Therapeutic inhibition of soluble brain TNF promotes remyelination by increasing myelin phagocytosis by microgliaTellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNSFibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis.Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitis.Depletion of blood-borne macrophages does not reduce demyelination in mice infected with a neurotropic coronavirus.Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus.Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis.Enhanced uptake of multiple sclerosis-derived myelin by THP-1 macrophages and primary human microglia.Role of macrophage activation in the pathogenesis of Alzheimer's disease and human immunodeficiency virus type 1-associated dementia.Role of spleen-derived monocytes/macrophages in acute ischemic brain injury.Tumor progression locus 2 (Tpl2) kinase promotes chemokine receptor expression and macrophage migration during acute inflammation.VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responses.Phagocytic properties of microglia in vitro: implications for a role in multiple sclerosis and EAE.Myelin-derived lipids modulate macrophage activity by liver X receptor activationCCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function.Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantationSelective upregulation of scavenger receptors in and around demyelinating areas in multiple sclerosis.EphA4 receptor tyrosine kinase is a modulator of onset and disease severity of experimental autoimmune encephalomyelitis (EAE)In silico investigation into dendritic cell regulation of CD8Treg mediated killing of Th1 cells in murine experimental autoimmune encephalomyelitisMolecular control of physiological and pathological T-cell recruitment after mouse spinal cord injuryClodronate liposomes: perspectives in research and therapeutics.A tumor necrosis factor receptor 1-dependent conversation between central nervous system-specific T cells and the central nervous system is required for inflammatory infiltration of the spinal cord.Myelin-phagocytosing macrophages modulate autoreactive T cell proliferationCannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice.Modulating phenotype and cytokine production of leucocytic retinal infiltrate in experimental autoimmune uveoretinitis following intranasal tolerance induction with retinal antigens.Macrophages in experimental autoimmune diseases in the rat: a review.In CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet beta-cell killing: studies from an acute model.Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice.Tyrosine kinase inhibitors ameliorate autoimmune encephalomyelitis in a mouse model of multiple sclerosisExperimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).Multiple sclerosis: myeloperoxidase immunoradiology improves detection of acute and chronic disease in experimental model.Multiple sclerosis and vitamin D: an update.Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation.
P2860
Q24801675-ADD6CD19-EF19-42DD-ADB8-2F377791E531Q26824619-3DEC8987-CB62-4001-BD6D-1009C48BDB72Q28537808-1CCC7B54-A6EF-4C7B-AD87-C27384216E11Q30395978-7CD96203-F5E7-4299-AA9C-C49DA4FD27FBQ30585165-B03DE6F5-95B3-4802-9F44-C3C5ECB1770CQ30840308-39614D3F-38D6-401B-8379-BFF4857AC0A2Q33359006-8128957D-D0B6-400E-831E-476EC20402BCQ33578973-48965D43-195B-496C-90E4-6823EC2E54C3Q33610978-3A46704A-8307-4640-A0A7-B78CDF3DA330Q33696788-5797AE83-13F4-456D-B5E5-A1301E00DECBQ33753656-0F3ABBD7-D43F-402D-AE18-28AC928BF6CAQ33816604-1E814236-B6D2-4EAC-B926-F446F0D5551DQ33821176-6388FDCC-3D90-4C00-9B1D-0C0A4827896FQ33841113-063094E5-8C6F-43D8-B7CE-917801A3961DQ33939178-F43E7FB0-9AA2-4C80-B80F-B63038226B1EQ33940352-53600CD0-EA37-4D37-83D0-0E8643B4B6BBQ34018642-C4E5E7D5-B5A8-4FA7-B70B-DE6FA652B5D6Q34076041-C036F054-F73E-42E6-8DEF-A256562BEEEBQ34277527-D8C4E2A9-5D30-402D-84B7-22A5C4EF457CQ34309554-AF5E25F8-9422-4C9C-BEB0-11D1D3A0116FQ34416303-CE0B7552-41C6-4BB1-ABD5-2B516DDA7BD8Q34417523-D63D170A-6FC7-4D2E-B440-EE3505E6D60CQ34498010-F68AEFE1-D765-4EFF-A32F-7242849E739BQ34555203-12D396AD-83D4-4DB3-B814-9CB82E44D4E5Q34580168-BA61ACC9-4EA9-4F90-BBD0-8F5D251CA84FQ34756248-482E968A-232B-4A0C-A8A8-AD8683C20FF1Q35052673-0ABE8186-E814-463D-924D-5537AB371025Q35072781-51A92A79-BF7B-48E1-BCFD-E2D8FC3AD98DQ35088195-252867B3-770D-4CA7-9C67-753818950A30Q35146791-81920FD1-448B-4273-AA45-777DD15F392CQ35193309-DF91D9E7-DAA3-4A6C-92C9-68B18B71315CQ35309706-5058EC3B-5546-4F3B-9CBF-CE6AFE672A7EQ35482947-BEAFF493-B157-48A4-98C9-4B507FD69B5CQ35569859-FC857095-2ECA-4BE6-A344-F36460CDBF57Q35569899-2C6EC666-0308-4358-B49B-F08F32E9B9F6Q35577914-094B8311-80D8-443B-992D-0C0D62000BF4Q35589934-849F568B-439F-4006-BF2B-844D34F668C3Q35683398-8170B70A-90BE-4ADC-973C-D81A1C66CDFBQ35726340-C9F59A16-69BA-44AE-8734-1F95338F88FEQ35742153-9A0610AF-A2BF-4903-875E-D4DD7F812348
P2860
Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Suppression of experimental al ...... er elimination of macrophages.
@en
Suppression of experimental al ...... er elimination of macrophages.
@nl
type
label
Suppression of experimental al ...... er elimination of macrophages.
@en
Suppression of experimental al ...... er elimination of macrophages.
@nl
prefLabel
Suppression of experimental al ...... er elimination of macrophages.
@en
Suppression of experimental al ...... er elimination of macrophages.
@nl
P2093
P2860
P356
P1476
Suppression of experimental al ...... er elimination of macrophages.
@en
P2093
Dijkstra CD
Huitinga I
Uitdehaag BM
de Groot CJ
van Rooijen N
P2860
P304
P356
10.1084/JEM.172.4.1025
P407
P577
1990-10-01T00:00:00Z